Skip to content

A study for Jian-Pi-Yi-Shen prescription in the treatment of chronic kidney stage III and its micro inflammation mechanism

A study for Jian-Pi-Yi-Shen prescription in the treatment of chronic kidney stage III and its micro inflammation mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018731
Enrollment
Unknown
Registered
2018-10-06
Start date
2018-10-31
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Case series:Oral Jian-Pi-Yi-Shen prescription

Sponsors

Shenzhen Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. According to the 2001 KDIGO guideline CKD3 diagnostic criteria 30 < eGFR < 59ml/min.1.73m2, and according to the 2002 edition of the guidelines for clinical research on the treatment of chronic renal failure by Chinese medicine new drug, the TCM syndrome differentiation is spleen-kidney qi deficiency accompanied by stasis syndrome; 2. Electrolyte disorders and hypertension were effectively controlled, and no other traditional Chinese medicine or proprietary Chinese medicine was taken during the treatment; 3. Men and women older than 18 years; 4. Agree to participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women and women who plan to become pregnant 2. Screening patients who had received other research drugs in the first 3 months 3. Patients who are known to be allergic to or unable to tolerate certain drugs in the study 4. Active liver disease, or abnormal liver function, myocardial infarction, or stroke, or congestive heart failure 5. The researchers considered it unsuitable for the study's patients 6. With history of serious illness.

Design outcomes

Primary

MeasureTime frame
CREATINE;

Countries

China

Contacts

Public ContactYANG SHU-DONG

Shenzhen Traditional Chinese Medicine Hospital

y.s.d@163.com+86 13688806568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026